Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Kary Eldred
6 Feb 2026
Director
Buy
300
$2.70
$810.00
Kary Eldred
23 Dec 2025
Director
Buy
700
$3.73
$2.61K
Kevin D Freeman
23 Dec 2025
Director
Buy
5,500
$3.55
$19.51K
Kary Eldred
23 Dec 2025
Director
Buy
700
$3.73
$2.61K
Kary Eldred
21 Jul 2025
Director
Buy
1,000
$2.93
$2.93K
Kevin D Freeman
17 Jul 2025
Director
Buy
5,000
$2.90
$14.50K
Harold H. Shlevin
30 Dec 2024
Director
Buy
6,500
$1.16
$7.54K
Kevin D Freeman
24 Dec 2024
Director
Buy
10,000
$0.81
$8.13K
Kary Eldred
24 Dec 2024
Director
Buy
13,469
$0.82
$11.04K
Richard A. Zordani Jr.
24 Dec 2024
Director
Buy
10,000
$0.82
$8.16K
Kary Eldred
23 Oct 2024
Director
Buy
500
$2.60
$1.30K
Kevin D Freeman
17 Oct 2024
Director
Buy
1,300
$2.64
$3.43K
Kevin D Freeman
16 Oct 2024
Director
Buy indirect
5,000
$2.70
$13.50K
Kevin D Freeman
16 Oct 2024
Director
Buy
5,000
$2.70
$13.50K
Richard A. Zordani Jr.
23 Aug 2024
Director
Buy
1,759
$2.30
$4.05K
Richard A. Zordani Jr.
23 Aug 2024
Director
Buy indirect
1,000
$2.30
$2.30K
Richard A. Zordani Jr.
22 Aug 2024
Director
Buy
741
$2.30
$1.70K
Kevin D Freeman
20 Jun 2024
Director
Buy
2,500
$2.38
$5.95K
Richard A. Zordani Jr.
30 Apr 2024
Director
Buy indirect
1,000
$3.52
$3.52K
Joel Lewis
24 Apr 2024
President and CEO
Buy indirect
1,000
$3.39
$3.39K
Kevin D Freeman
22 Apr 2024
Director
Buy
2,500
$2.98
$7.45K
Kary Eldred
16 Jan 2024
Director
Buy
500
$1.79
$892.90
Kary Eldred
16 Jan 2024
Director
Buy
400
$2.39
$956.00
Kary Eldred
19 Jul 2023
Director
Buy
1,598
$1.79
$2.85K
Kary Eldred
21 Feb 2023
Director
Buy
1,000
$1.59
$1.59K
Joel Lewis
16 Feb 2023
President and CEO
Buy indirect
1,000
$1.52
$1.52K
Kary Eldred
25 Jan 2023
Director
Buy
1,300
$1.11
$1.44K
Jack W Callicutt
17 Nov 2022
Chief Financial Officer
Buy
4,000
$1.32
$5.28K
Kevin D Freeman
28 Oct 2022
Director
Buy indirect
10,000
$1.41
$14.10K
Richard A. Zordani Jr.
28 Jul 2022
Director
Buy
5,000
$2.50
$12.50K
Kevin D Freeman
19 May 2022
Director
Buy indirect
5,000
$1.33
$6.65K
Kevin D Freeman
18 Apr 2022
Director
Buy indirect
5,000
$1.71
$8.55K
Richard A. Zordani Jr.
4 Apr 2022
Director
Buy
5,000
$1.61
$8.03K
Elissa J. Schwartz
21 Jan 2022
Director
Buy
1,000
$2.00
$2.00K
Kevin D Freeman
19 Jan 2022
Director
Buy indirect
5,000
$1.96
$9.81K
Richard A. Zordani Jr.
14 Jan 2022
Director
Buy
5,000
$2.02
$10.10K
Kevin D Freeman
6 Dec 2021
Director
Buy indirect
5,000
$2.34
$11.70K
Kevin D Freeman
6 Dec 2021
Director
Buy indirect
5,000
$2.28
$11.40K
Kevin D Freeman
29 Oct 2021
Director
Buy indirect
2,000
$3.17
$6.34K
Kevin D Freeman
21 Oct 2021
Director
Buy indirect
2,000
$3.19
$6.38K
Kevin D Freeman
19 Oct 2021
Director
Buy indirect
3,000
$3.37
$10.11K
Kevin D Freeman
23 Sep 2021
Director
Buy indirect
3,000
$3.88
$11.63K
Kevin D Freeman
5 Apr 2021
Director
Buy indirect
5,000
$2.04
$10.20K
Richard E Uihlein
4 Sep 2020
Director
Buy
10,000
$2.55
$25.50K
Kevin D Freeman
4 Sep 2020
Director
Buy indirect
5,000
$2.57
$12.85K
Kevin D Freeman
19 Mar 2020
Director
Buy indirect
6,000
$1.64
$9.84K
Kevin D Freeman
15 Nov 2019
Director
Buy indirect
3,000
$3.36
$10.08K
Kevin D Freeman
6 Sep 2019
Director
Buy indirect
1,290
$3.71
$4.79K
Richard E Uihlein
31 May 2019
Director
Buy indirect
7,710
$4.28
$33.00K
Richard E Uihlein
31 May 2019
Director
Buy
4,672,896
$4.28
$20.00M
Joel Lewis
31 May 2019
Director
Buy
12,849
$4.28
$54.99K
Gilbert S Omenn
31 May 2019
Director
Buy
18,578
$4.28
$79.51K
Kevin D Freeman
31 May 2019
Director
Buy
1,426
$4.28
$6.10K
Kevin D Freeman
31 May 2019
Director
Buy indirect
7,710
$4.28
$33.00K
Kary Eldred
31 May 2019
Director
Buy
3,033
$4.28
$12.98K
Jack W Callicutt
31 May 2019
Chief Financial Officer
Buy
2,354
$4.28
$10.08K
Richard E Uihlein
9 Apr 2019
Director
Buy
20,700
$4.82
$99.85K
Kevin D Freeman
5 Apr 2019
Director
Buy indirect
500
$4.73
$2.37K
Richard E Uihlein
5 Apr 2019
Director
Buy
21,000
$4.81
$100.97K
Joel Lewis
5 Apr 2019
Director
Buy
667
$4.82
$3.21K
Kevin D Freeman
8 Feb 2019
Director
Buy indirect
1,500
$4.29
$6.43K
Joel Lewis
7 Feb 2019
Director
Buy
1,000
$4.48
$4.48K
Richard E Uihlein
29 Jan 2019
Director
Buy
48,500
$4.87
$236.24K
Joel Lewis
29 Jan 2019
Director
Buy
1,000
$4.81
$4.81K
Richard E Uihlein
28 Jan 2019
Director
Buy
3,000
$4.77
$14.32K
Kary Eldred
25 Sep 2018
Director
Buy
2,000
$6.10
$12.20K
Joel Lewis
25 Jun 2018
Director
Buy
1,000
$7.06
$7.06K
Kevin D Freeman
1 Feb 2018
Director
Buy indirect
2,000
$4.10
$8.19K
Kevin D Freeman
1 Feb 2018
Director
Buy indirect
2,000
$4.10
$8.19K
Showing 250 of 254 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 386
Amendments (4/A) skipped 24
Filings about a different issuer 0
Unreadable filings 0
Joint filings 35
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 83
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 46,004,203
Sales filed before the plan box existed 58
History held since 9 Feb 2007